opiate withdrawal

From Aaushi
Jump to navigation Jump to search

Introduction

Also see opioid receptor agonist &/or substance withdrawal

Etiology

Clinical manifestations

Differential diagnosis

Management

More general terms

More specific terms

Additional terms

References

  1. 1.0 1.1 Clopton J. Medscape. Sep 28, 2016. What Is Kratom? Why Does the DEA Want to Ban It? http://www.medscape.com/viewarticle/869404
  2. 2.0 2.1 FDA News Release. Nov 15, 2017 FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm585271.htm
    Miranda A, Taca A. Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment. Am J Drug Alcohol Abuse. 2018;44(1):56-63. Epub 2017 Mar 16. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28301217
  3. 3.0 3.1 Orciari Herman A, Sadoughi S, Saitz R Nerve Stimulator for Opioid Withdrawal Called into Question. Physician's First Watch, May 3, 2018 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
    Harper J Questions Raised About Study Of Device To Ease Opioid Withdrawal. Health News from NPR. May 2, 2018 https://www.npr.org/sections/health-shots/2018/05/02/602908208/questions-raised-about-study-of-device-to-ease-opioid-withdrawal
  4. 4.0 4.1 4.2 4.3 4.4 4.5 NEJM Knowledge+ Psychiatry
  5. Medical Knowledge Self Assessment Program (MKSAP) 19 American College of Physicians, Philadelphia 2021
  6. 6.0 6.1 6.2 6.3 NEJM Knowledge+ Pain Management and Opioids: Recharge